PharmAsia News' Top Industry Trends Of 2009
This article was originally published in PharmAsia News
Executive Summary
As PharmAsia News wraps up its second year of publishing, we look back to some of the top trends and stories of 2009, as well as developing stories to keep an eye on in 2010
You may also be interested in...
China Boosts Health System Reforms With Expanded National Drug Reimbursement List
BEIJING - In the government's latest move to expand coverage under sweeping health system reforms that are in the works China-wide, the Ministry of Human Resources and Social Security has added hundreds of new medicines to the latest edition of the national drug reimbursement catalog
Investment Outlook For China And India Too Hot? VCs Anticipate Market Corrections - PharmAsia Summit
SAN FRANCISCO - Investors have not felt the pinch of the financial crisis in China and India as much as they have in the West, investors told PharmAsia Summit attendees in San Francisco Oct. 28
Partnering Better Than Solo Play For Biosimilars, Says Dr. Reddy's CEO; Limited Growth In Generics Will Lead To Moves For Innovative Drugs
MUMBAI - With six biosimilar compounds in the works and two launched in the Indian market, India's second largest generic drug maker - Dr. Reddy's Labs - is negotiating with several multinational companies to broaden its presence in Western markets